Nebula Research & Development LLC Tactile Systems Technology Inc Transaction History

Nebula Research & Development LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$11.13 - $15.8 $42,883 - $60,877	3,853 Added 21.66%	21,642 $258 Million
Q1 2024 May 15, 2024	SELL	$13.63 - $16.75 $159,893 - $196,494	-11,731 Reduced 39.74%	17,789 $289 Million
Q4 2023 Feb 14, 2024	BUY	$9.95 - $14.73 $127,797 - $189,192	12,844 Added 77.02%	29,520 $422 Million
Q3 2023 Nov 14, 2023	BUY	$12.95 - $25.63 $105,011 - $207,833	8,109 Added 94.65%	16,676 $234 Million
Q2 2023 Aug 14, 2023	BUY	$16.36 - $24.93 $140,156 - $213,575	8,567 New	8,567 $214 Million

129

21.7M

13.8K

900

Ticker TCMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,132,100
Market Cap $346M
Description
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for th...

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

Stay updated on Nebula Research & Development LLC with notifications on news.